Johnson & Johnson Innovation – JLABS @ Washington, DC

In partnership with Children’s National Hospital, Johnson & Johnson Innovation – JLABS (‘JLABS’) opened JLABS @ Washington, DC at the new Children’s National Research & Innovation Campus in Washington, D.C. The high-tech site includes 32,000 square feet of lab, prototype, office and conference room space, providing millions of dollars of laboratory instrumentation and specialty equipment to support the JLABS @ Washington, DC portfolio of companies.

The JLABS @ Washington, DC site is open to pharmaceutical, medical device, consumer and health technology companies that are aiming to advance the development of new drugs, medical devices, precision diagnostics and health technologies, including applications in pediatrics.

Johnson & Johnson Innovation seeks to find the best science and technology, no matter where it is located, aiming to solve the greatest unmet medical and healthcare needs of our time. JLABS, in addition to offering emerging life science companies modular lab units, office space, shared core laboratory equipment and business facilities, links entrepreneurs within the District and across the greater Virginia and Maryland regions with the full breadth of the Johnson & Johnson Innovation model, including opportunities for funding, third-party services, educational events and R&D experts from medical technology, consumer healthcare product and Janssen pharmaceutical teams.

Applications to join JLABS @ Washington, DC and other JLABS sites are being accepted from biotech, pharmaceutical, medical device, consumer health and health technology companies on a rolling basis. Visit the JLABS @ Washington, DC website to learn more.

View the photo gallery and video from the exciting announcement of this partnership.

BLUE KNIGHT ™ at JLABS @ Washington, DC

JLABS @ Washington, DC serves as the hub for BLUE KNIGHT. Created in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, BLUE KNIGHT aims to stimulate the innovation and incubation of science and technologies that may improve health security and response by supporting companies focused on public health threats and emerging infectious disease.

Learn more about BLUE KNIGHT.

**Washington, D.C., Mayor Muriel Bowser** Washington, D.C., Mayor Muriel Bowser at the podium during announcement of JLABS @ D.C., press conference.

**JLABS @ Washington, DC.** Sharing in our exciting announcement that Children’s National and Johnson & Johnson Innovation will launch JLABS @ Washington, DC.

**Melinda Richter, Global Head of Johnson & Johnson Innovation** Melinda Richter, Global Head of Johnson & Johnson Innovation at press conference.

**JLABS @ DC announcement** Press conference leaders and speakers

**Children's National leaders** Group of leaders from Children's National Hospital during the JLABS @ DC announcement.

Subscribe to The Children’s National Research & Innovation Campus Newsletter

Stay informed by signing up for Children’s National Research & Innovation Campus Updates.